Kane Biotech

Kane Biotech is THE Biofilm Company, engaged in the research, development, and commercialization of technologies that break up biofilms and destroy bacteria.

[Kane Biotech @KaneBio]

Biofilms may be an uncommon word, but they impact our lives and health in many ways – including keeping us sick. A biofilm is a glue-like substance excreted by bacteria & fungi to attach to surfaces that “houses”, protects, & allows bacteria to thrive in hostile environments.

[Kane Biotech @KaneBio]

As many as one out of every 25 patients admitted in the U.S. leaving with a new pathogen, according to the CDC. And in many cases, biofilms are to blame. Learn more: https://t.co/DAPKHTUylP

#biofilm #bacteria #biotech #biotechnology #biofilms #woundcare #medical

[Kane Biotech @KaneBio]

Biofilm formation in burn wounds is similar to other skin wounds but with several important differences. Learn more: https://t.co/kBHI43CjUY
#kanebio #biofilm #burns #bacteria #health #medical #medicaldevice #biofilms #biotechnology #smallcap #biotech #woundcare #woundhealing

[Kane Biotech @KaneBio]

@KaneBio announced their partnership in Nov. with ProgenaCare to launch its revyve™ Antimicrobial #Wound Gel. “We are excited to share this cutting-edge product and the new revyve™ brand with the larger wound care community,” stated Howard Walthall, CEO of ProgenaCare.

[Kane Biotech @KaneBio]

Kane Biotech has filed a patent on its revyve™ Antimicrobial Wound Gel Spray, a follow-on product to its FDA 510(k) cleared revyve™ Antimicrobial Wound Gel. Kane is in the final stages of development of this product which is still pending FDA clearance. #biofilm #medical

[Kane Biotech @KaneBio]

Kane Biotech's CSO, Greg Schultz, PhD, did an excellent job at the #BoswickSymposium presenting revyve™ Antimicrobial Wound Gel Spray, which @KaneBio has filed a #patent on and is a follow-on product to its FDA 510(k) cleared revyve™ Antimicrobial #Wound Gel.

[International Wound Journal @IntWoundJournal]

The Estimated Costs of Wounds in the USA and Its States: The International Wound Journal recently published an editorial showing what the USA and its individual states could be spending on managing wounds.
https://t.co/oFOeCFS8Li

#woundcare #wounds #costs #IWJ #USA

[Kane Biotech @KaneBio]

Kane Biotech announces that it has filed a patent on its revyve™ Antimicrobial Wound Gel Spray, a follow-on product to its FDA 510(k) cleared revyve™ Antimicrobial Wound Gel, and will be introducing it at the Boswick Burn and Wound Care Symposium. https://t.co/ksXXJOrw4H

[Kane Biotech @KaneBio]

Kane is at the forefront of where innovation and discovery are created. Kane's labs are located in the University of Manitoba Smartpark Innovation Hub, &include 2 independent analytical laboratories & 3 independent microbiology suites.
Take a 3D lab tour: https://t.co/SXZqRFe2db

[Kane Biotech @KaneBio]

@KaneBio will be presenting its revyve™ Antimicrobial Wound Gel at the Boswick Burn and Wound Care Symposium. The international conference will take place from January 27 to February 1, 2024. Read more: https://t.co/RaZTFvkucU

#surgical #medical #woundcare #woundgel #revyve

[Kane Biotech @KaneBio]

Biofilm-impaired healing is the LARGEST unresolved problem in #WoundCare as #biofilms make #bacteria up to 1,000x more resistant to #antibiotics and #antimicrobials. @KaneBio, with 80 patents and #patents pending, is leading the charge against biofilm. https://t.co/2c5YlSOT2P

[Kane Biotech @KaneBio]

@KaneBio announced that on February 20, 2024, the Company will hold a special meeting of its shareholders to consider the election of Dr. Robert Huizinga as an additional director of the Company. Learn more: https://t.co/oGxAqTd8sw

[Kane Biotech @KaneBio]

revyve™ Antimicrobial Wound Gel developed by @KaneBio is indicated for the use on:
*Partial and full thickness wounds
*Leg #ulcers
*Large surface area #wounds
*Pressure ulcers
*#Surgical incisions
*1st and 2nd degree #burns
*#Diabetic foot ulcers
Visit: https://t.co/NeaFDFxfAy

[Kane Biotech @KaneBio]

Did you know? Keeping you sick is the ultimate goal of #biofilm. Biofilms make bacteria up to 1,000 times more resistant to #antibiotics and #antimicrobials, protecting the #bacteria which then affects the immune system. Learn more: https://t.co/MTaAdKRorn

[Kane Biotech @KaneBio]

The largest organ in a human body is the skin, and each person’s #skin is 100% unique. @DermaKb products are developed by @KaneBio, who is leading the advancement of #technologies and #products that break up #biofilms and destroy #bacteria. Learn more: https://t.co/tJdjhUskfo

[International Wound Journal @IntWoundJournal]

The Costs of Wounds in the UK: The International Wound Journal recently published an editorial showing what the UK countries could be spending on managing wounds.

https://t.co/w1nlipiNjx

#wounds #woundcare #costs #IWJ #UK

[Biofilm Journal @BiofilmJournal]

New @BiofilmJournal review on Staphylococcus aureus biofilm: Formulation, regulatory, and emerging natural products-derived therapeutics

https://t.co/o5cRJoMfav

[Kane Biotech @KaneBio]

DID YOU KNOW? On December 19, 2023, Kane Biotech announced it signed a non-binding offer for the sale of its interest in STEM Animal Health Inc. Read full press release: https://t.co/tK5RYS7e4k

#petcare #biotech #biotechnology #biofilm #stem #pressrelease #animalhealth #pets

[Kane Biotech @KaneBio]

Kane Biotech announces a correction to its press release dated December 28, 2023. https://t.co/xjcFfCv65s

[Kane Biotech @KaneBio]

**PRESS RELEASE** Kane Biotech (TSX-V:KNE OTCQB:KNBIF) Announces Amendment to its Credit Facility. Read full press release here: https://t.co/tEQzN8G86O

#biotech #biofilm #biotechnology #smallcap #kanebio #tsx #pressrelease #biofilm #woundcare #pethealth #Innovation